CNC vs OSCR
Centene Corporation and Oscar Health, Inc., both Healthcare
Centene Corporation is the larger company at $30B against $8.6B. Over the past year CNC returned +160% against +106% for OSCR. Ryufin's sector-relative Smart Score puts OSCR ahead, 10/10 against 8/10.
| Figure | CNC | OSCR |
|---|---|---|
| Last close | $65.47 | $31.24 |
| Market cap | $30B | $8.6B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | n/a | 24.0 |
| 1-year return | +160% | +106% |
| 5-year return | -4.6% | +93% |
| Ryufin Smart Scoresector-relative, 1–10 | 8/10 | 10/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Centene Corporation
Revenue of $54B in Q2 2026, net income $1.1B. Its largest reported line is Medicaid, 54% of the disclosed total.
Oscar Health, Inc.
Revenue of $4.9B in Q2 2026, net income $362M.
Open these two in the interactive comparison to add more names, change the period or read the correlation.